دورية أكاديمية
Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study.
| العنوان: | Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study. |
|---|---|
| المؤلفون: | Mathiesen JS; Department of ORL Head & Neck SurgeryOdense University Hospital, Odense, Denmark jes_mathiesen@yahoo.dk.; Department of Clinical ResearchUniversity of Southern Denmark, Odense, Denmark., Kroustrup JP; Department of Clinical Medicine and EndocrinologyAalborg University Hospital, Aalborg, Denmark., Vestergaard P; Department of Clinical Medicine and EndocrinologyAalborg University Hospital, Aalborg, Denmark., Stochholm K; Department of Internal Medicine and EndocrinologyAarhus University Hospital, Aarhus, Denmark.; Center for Rare DiseasesAarhus University Hospital, Aarhus N, Denmark., Poulsen PL; Department of Internal Medicine and EndocrinologyAarhus University Hospital, Aarhus, Denmark., Rasmussen ÅK; Department of Medical EndocrinologyCopenhagen University Hospital, Copenhagen, Denmark., Feldt-Rasmussen U; Department of Medical EndocrinologyCopenhagen University Hospital, Copenhagen, Denmark., Schytte S; Department of ORL Head & Neck SurgeryAarhus University Hospital, Aarhus, Denmark., Londero SC; Department of ORL Head & Neck SurgeryAarhus University Hospital, Aarhus, Denmark., Pedersen HB; Department of ORL Head & Neck SurgeryAalborg University Hospital, Aalborg, Denmark., Hahn CH; Department of ORL Head & Neck SurgeryCopenhagen University Hospital, Copenhagen, Denmark., Djurhuus BD; Department of ORL Head & Neck SurgeryZealand University Hospital, Køge, Denmark., Bentzen J; Department of OncologyHerlev Hospital, Herlev, Denmark., Möller S; Department of Clinical ResearchUniversity of Southern Denmark, Odense, Denmark.; Odense Patient data Explorative Network (OPEN)Odense University Hospital, Odense, Denmark., Gaustadnes M; Department of Molecular MedicineAarhus University Hospital, Aarhus, Denmark., Rossing M; Center for Genomic MedicineCopenhagen University Hospital, Copenhagen, Denmark., Nielsen FC; Center for Genomic MedicineCopenhagen University Hospital, Copenhagen, Denmark., Brixen K; Department of Clinical ResearchUniversity of Southern Denmark, Odense, Denmark., Frederiksen AL; Department of Clinical ResearchUniversity of Southern Denmark, Odense, Denmark.; Department of Clinical GeneticsOdense University Hospital, Odense, Denmark., Godballe C; Department of ORL Head & Neck SurgeryOdense University Hospital, Odense, Denmark. |
| مؤلفون مشاركون: | Danish Thyroid Cancer Group (DATHYRCA) |
| المصدر: | Endocrine connections [Endocr Connect] 2018 Jun; Vol. 7 (6), pp. 829-839. Date of Electronic Publication: 2018 May 14. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioScientifica Country of Publication: England NLM ID: 101598413 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2049-3614 (Print) Linking ISSN: 20493614 NLM ISO Abbreviation: Endocr Connect Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Bristol : BioScientifica |
| مستخلص: | Recent studies have shown a significant increase in the temporal trend of medullary thyroid carcinoma (MTC) incidence. However, it remains unknown to which extent sporadic medullary thyroid carcinoma (SMTC) and hereditary MTC (HMTC) affect the MTC incidence over time. We conducted a nationwide retrospective study using previously described RET and MTC cohorts combined with review of medical records, pedigree comparison and relevant nationwide registries. The study included 474 MTC patients diagnosed in Denmark between 1960 and 2014. In the nationwide period from 1997 to 2014, we recorded a mean age-standardized incidence of all MTC, SMTC and HMTC of 0.19, 0.13 and 0.06 per 100,000 per year, respectively. The average annual percentage change in incidence for all MTC, SMTC and HMTC were 1.0 ( P = 0.542), 2.8 ( P = 0.125) and -3.1 ( P = 0.324), respectively. The corresponding figures for point prevalence at January 1, 2015 were 3.8, 2.5 and 1.3 per 100,000, respectively. The average annual percentage change in prevalence from 1998 to 2015 for all MTC, SMTC and HMTC was 2.8 ( P < 0.001), 3.8 ( P < 0.001) and 1.5 ( P = 0.010), respectively. We found no significant change in the incidence of all MTC, SMTC and HMTC possibly due to our small sample size. However, due to an increasing trend in the incidence of all MTC and opposing trends of SMTC (increasing) and HMTC (decreasing) incidence, it seems plausible that an increase for all MTC seen by others may be driven by the SMTC group rather than the HMTC group. (© 2018 The authors.) |
| References: | Scand J Public Health. 2011 Jul;39(7 Suppl):72-4. (PMID: 21775357) Endocr Relat Cancer. 2016 Apr;23(4):313-22. (PMID: 26917552) Thyroid. 2012 Jan;22(1):27-34. (PMID: 22216985) Ugeskr Laeger. 2014 Jan 27;176(5A):. (PMID: 27498810) Acta Oncol. 1990;29(1):9-15. (PMID: 2310607) Cancer. 2012 Feb 1;118(3):620-7. (PMID: 21717441) JAMA. 2017 Apr 4;317(13):1338-1348. (PMID: 28362912) Endocr Relat Cancer. 2017 Jul;24(7):L39-L42. (PMID: 28438782) Clin Endocrinol (Oxf). 2015 Jun;82(6):892-9. (PMID: 25440022) Endocr Relat Cancer. 2013 Mar 26;20(2):263-71. (PMID: 23447568) Future Oncol. 2010 Nov;6(11):1771-9. (PMID: 21142662) Am J Hum Genet. 1997 Jan;60(1):233-7. (PMID: 8981969) Eur J Endocrinol. 2013 Feb 15;168(3):307-14. (PMID: 23211574) Ann Oncol. 2011 Apr;22(4):957-63. (PMID: 20952599) Clin Nucl Med. 2002 Dec;27(12):868-70. (PMID: 12607865) J Clin Endocrinol Metab. 1996 Oct;81(10):3740-5. (PMID: 8855832) Clin Endocrinol (Oxf). 1998 Mar;48(3):265-73. (PMID: 9578814) Mol Cell Endocrinol. 1998 Feb;137(1):51-7. (PMID: 9607728) Cancer Epidemiol. 2014 Oct;38(5):633-7. (PMID: 25132423) Cancer. 2000 Aug 15;89(4):863-7. (PMID: 10951350) Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):784-91. (PMID: 19240234) Hum Mutat. 2009 Apr;30(4):548-56. (PMID: 19177457) Surgery. 2010 Dec;148(6):1147-52; discussion 1152-3. (PMID: 21134545) Henry Ford Hosp Med J. 1984;32(4):238-43. (PMID: 6152458) Clin Endocrinol (Oxf). 1995 Jul;43(1):123-7. (PMID: 7641404) J Clin Endocrinol Metab. 2017 Jun 1;102(6):2069-2074. (PMID: 28323957) Scand J Public Health. 2011 Jul;39(7 Suppl):42-5. (PMID: 21775350) J Clin Endocrinol Metab. 1998 Mar;83(3):770-4. (PMID: 9506724) Eur Arch Otorhinolaryngol. 2010 Apr;267(4):613-7. (PMID: 19823860) Thyroid. 2013 Jun;23(6):748-57. (PMID: 23410185) Scand J Clin Lab Invest. 1999 Dec;59(8):643-7. (PMID: 10691056) Nat Rev Endocrinol. 2016 Nov;12(11):646-653. (PMID: 27418023) Thyroid. 2009 Jun;19(6):565-612. (PMID: 19469690) Acta Ophthalmol Scand. 2007 Feb;85(1):120-1. (PMID: 17244227) Surgery. 2017 Jan;161(1):137-146. (PMID: 27842913) Ir J Med Sci. 2017 Feb;186(1):89-95. (PMID: 27083464) Scand J Public Health. 2011 Jul;39(7 Suppl):30-3. (PMID: 21775347) Thyroid. 2017 Feb;27(2):215-223. (PMID: 27809725) Thyroid. 2015 Jun;25(6):567-610. (PMID: 25810047) Eur J Endocrinol. 2009 Jan;160(1):71-9. (PMID: 18952764) Auris Nasus Larynx. 2016 Oct;43(5):551-5. (PMID: 26837867) Thyroid. 2017 Dec;27(12):1505-1510. (PMID: 29020875) Thyroid. 2017 Aug;27(8):1103-1104. (PMID: 28578594) Cancer Epidemiol. 2016 Sep;44 Suppl 1:S150-S157. (PMID: 27678317) Thyroid. 2015 Jan;25(1):139-40. (PMID: 25244518) J Clin Oncol. 2001 Mar 1;19(5):1374-80. (PMID: 11230481) |
| فهرسة مساهمة: | Keywords: Denmark; hereditary medullary thyroid carcinoma; incidence; prevalence; sporadic medullary thyroid carcinoma |
| تواريخ الأحداث: | Date Created: 20180516 Latest Revision: 20220331 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC6000757 |
| DOI: | 10.1530/EC-18-0157 |
| PMID: | 29760189 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2049-3614 |
|---|---|
| DOI: | 10.1530/EC-18-0157 |